The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of O'neill Gilmore Neil since 2019.
This trader's CIK number is 1742084.
At the time of last reporting, O'neill Gilmore Neil was the CEO of Editas Medicine, Inc.. (stock ticker symbol EDIT).
Also see all insider trading activities at Editas Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | SRPT | 0 | $0 | 0 | $0 | 12,000 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | EDIT | 0 | $0 | 37,416 | $69,164 | 0 | $0 |
| 2024 | EDIT | 0 | $0 | 93,188 | $808,554 | 0 | $0 |
| 2023 | EDIT | 0 | $0 | 6,486 | $61,636 | 0 | $0 |
1. Sarepta Therapeutics, Inc. (SRPT)
2. Editas Medicine, Inc. (EDIT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-23 | SRPT | Option Ex | 12,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | EDIT | Sale | 5,592 | 2.60 | 14,516 |
| 2025-06-03 | EDIT | Sale | 15,192 | 1.72 | 26,191 |
| 2025-03-04 | EDIT | Sale | 16,632 | 1.71 | 28,457 |
| 2024-12-03 | EDIT | Sale | 1,618 | 2.08 | 3,360 |
| 2024-09-04 | EDIT | Sale | 1,555 | 3.42 | 5,325 |
| 2024-06-04 | EDIT | Sale | 12,191 | 5.50 | 67,001 |
| 2024-03-05 | EDIT | Sale | 77,824 | 9.42 | 732,868 |
| 2023-06-05 | EDIT | Sale | 6,486 | 9.50 | 61,636 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'neill Gilmore Neil (CEO of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.